Cutaneous mesenchymal tumors treated with Mohs micrographic surgery: a comprehensive review
- 14 March 2021
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (11), 1334-1342
- https://doi.org/10.1111/ijd.15500
Abstract
Cutaneous mesenchymal tumors (CMT) are rare tumors with wide clinicopathologic heterogeneity. Treatment of malignant cutaneous mesenchymal tumors traditionally includes wide local excision (WLE), though Mohs micrographic surgery (MMS) has been increasingly used. A PubMed literature review of articles from inception until September 2019 related to malignant CMT and surgical treatment with MMS or WLE was completed. Dermatofibrosarcoma protuberans treated with MMS recurred in 1.2% of patients with no reported metastasis. Atypical fibroxanthoma treated with MMS recurred and metastasized in 2.7 and 2.5%, respectively. Undifferentiated pleomorphic sarcoma treated with MMS recurred in 32% with an unknown metastatic rate. Superficial leiomyosarcoma treated with MMS recurred in 3.8% with no reported metastasis. Cutaneous angiosarcoma and myofibrosarcoma treated with MMS have shown no recurrence or metastatic disease, but literature is sparse. The rarity of malignant CMT and the lack of comparative data on treatment make conclusive treatment recommendations difficult. However, recent literature suggests MMS is a useful option and potentially a superior treatment for primary cutaneous mesenchymal tumors.Keywords
This publication has 67 references indexed in Scilit:
- Cutaneous angiosarcoma of the head, neck, and face of the elderly in type 5 skinJournal of Cutaneous and Aesthetic Surgery, 2013
- Management of Unusual Cutaneous Malignancies: Atypical Fibroxanthoma, Malignant Fibrous Histiocytoma, Sebaceous Carcinoma, Extramammary Paget DiseaseDermatologic Clinics, 2011
- CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanomaJournal of Cutaneous Pathology, 2010
- Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a reviewJournal of Cutaneous Pathology, 2010
- Slow Mohs increasing histopathology identification of angiosarcomaJournal of the American Academy of Dermatology, 2009
- Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002Journal of the American Academy of Dermatology, 2007
- Malignant fibrous histiocytoma: Outcome of tumours in the head and neck compared with those in the trunk and extremitiesBritish Journal of Oral and Maxillofacial Surgery, 2006
- Discriminant analysis of prognostic factors for malignant fibrous histiocytoma in soft tissueJournal of Orthopaedic Science, 2001
- Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: Results of a multiinstitutional series with an analysis of the extent of microscopic spreadJournal of the American Academy of Dermatology, 1997
- Prognostic factors in 227 patients with malignant fibrous histiocytomaCancer, 1992